Johnson & Johnson (J&J) is in the midst of attempting to finalize a historic settlement of thousands of cancer-related lawsuits through the bankruptcy of its subsidiary: Red River Talc. However, two U.S. federal health agencies – the Department of Veterans Affairs (VA) and the Department of Health & Human Services (HHS) – are challenging the proposal, raising concerns about the potential impact on the government’s ability to recover health care costs.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,